Homefinancing

financing

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

financing

$100m climatech fund launched

admin - May 12, 2025

financing

Cocoon Capital looks to boost deeptech startups with $50m fund

Jim Cornall - May 8, 2025

automation

India calls for deep tech support

Jim Cornall - May 5, 2025

financing

TDK Ventures looks to help deeptech startups

Jim Cornall - April 30, 2025

financing

Accenture Acquires TalentSprint

Jim Cornall - April 29, 2025

financing

New deeptech incubators in Israel aim to launch dozens of startups

Jim Cornall - April 21, 2025

financing

NUS expands start-up hub in Tokyo to propel deeptech innovation

Jim Cornall - April 9, 2025

financing

Partnership looks to boost deeptech in Oman

Jim Cornall - February 28, 2025

12 3 Page 1 of 3

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0